HIV Treatment and Program Preferences Among Ryan White Clients in New York City in the Era of Long-Acting Injectable ART: A Discrete Choice Experiment
Assessing preferences among groups under-represented in clinical trials is essential to effective and equitable real-world implementation of innovative treatment options. Our study found that there were distinct groups that differed in their preferred ART regimen type and that New York RWPA MCM clients had limited familiarity with LAI ART. To inform regimen selection, we began pilot-testing educational materials and a patient-provider decision-making tool in 2023.
Authors
- Mary Kathryn Irvine (ORCID: https://orcid.org/0000-0003-1852-7559)
- Connor Emmert (ORCID: https://orcid.org/0009-0008-9691-1146)
- Jennifer M. Carmona (ORCID: https://orcid.org/0009-0002-7240-9625)
- Meghan Peterson (ORCID: https://orcid.org/0009-0009-8621-4256)
- Elizabeth A. Kelvin (ORCID: https://orcid.org/0000-0002-0566-8697)
- Tigran Avoundjian (ORCID: https://orcid.org/0000-0001-6202-2043)
- Denis Nash
- Sarah Kulkarni
- Rebecca Zimba
Institutions
- New York City Department of Health and Mental Hygiene (US)
- City University of New York (US)
- Institute for Family Health (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-02-16
- DOI
- https://doi.org/10.64898/2026.02.13.26346257
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- City University of New York
- Health Resources and Services Administration
- Center for AIDS Research, University of Washington
- National Institute of Mental Health